ask="4.48"
ask_size="300"
average_daily_volume="49158"
bid="4.13"
bid_size="1000"
book_value="5.08"
change="+0.02"
change_from_200_day_moving_average="-1.42"
change_from_50_day_moving_average="-0.48"
change_from_52_week_high="-8.54"
change_From_52_week_low="0.55"
change_in_percent="+0.50%"
close="4.21"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="4.38"
high_52_weeks="12.75"
last_trade_date="2/8/2017"
last_trade_price="4.21"
last_trade_size="146"
last_trade_time="4:00pm"
low="4.10"
low_52_weeks="3.66"
market_capitalization="56.54M"
moving_average_200_day="5.63"
moving_average_50_day="4.69"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.19"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-25.26%"
percent_change_from_50_day_moving_average="-10.17%"
percent_change_from_52_week_high="-66.98%"
percent_change_from_52_week_low="+15.03%"
previous_close="4.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.82"
price_per_sales="11.33"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="1.42"
stock_exchange="NGM"
symbol="AGLE"
volume="91343"
weeks_range_52="3.66 - 12.75"
